EPRX
Eupraxia Pharmaceuticals
EPRX
EPRX
27 hedge funds and large institutions have $75.3M invested in Eupraxia Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
30.15% more ownership
Funds ownership: 5.48% → 35.63% (+30%)
Holders
27
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$23.9M | |
| 2 | +$7.96M | |
| 3 | +$7.96M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.08M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$5.4M |
Top Sellers
| 1 | -$108K | |
| 2 | -$80.1K | |
| 3 | -$61.4K | |
| 4 |
JP Morgan Chase
New York
|
-$13.3K |
